This leader will shape and lead value and access submission and negotiation planning, including optimal country launch sequence and ensure sustainable access in key European markets. This role will be a core member of the Europe Region leadership team, working cross-functionally to influence long-term growth and patient impact, to build a global multi-billion company serving patients suffering from rare neuro-muscular diseases.